Perrigo Company plc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
$PRGO
Biotechnology: Pharmaceutical Preparations
Health Care
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________________________________________
FORM 8-K
______________________________________________
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
______________________________________________
(Exact name of registrant as specified in its charter)
_______________________________________________
Commission file number 001-36353
| Not Applicable | ||||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
+353 1 7094000
(Address, including zip code, and telephone number, including
area code, of registrant’s principal executive offices)
Not Applicable
(Former name or former address, if changed since last report)
________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
(17 CFR 230.425)
(17 CFR 240.14a-12)
(17 CFR 240.14d-2(b))
(17 CFR 240.13e-4(c))
Securities Registered pursuant to section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
At the Company's Annual General Meeting of Shareholders held on May 1, 2025, the Company's shareholders voted on the following matters:
1.Election of directors to hold office until the 2026 Annual General Meeting of Shareholders:
| Nominee | For | Against | Abstain | Broker Non-Votes | ||||||||||||||||||||||
| Bradley A. Alford | 113,193,826.68 | 1,194,953.00 | 115,015.94 | 8,298,056.68 | ||||||||||||||||||||||
| Orlando D. Ashford | 108,958,421.48 | 5,438,948.20 | 106,425.94 | 8,298,056.68 | ||||||||||||||||||||||
Julia M. Brown | 110,209,502.48 | 4,192,719.20 | 101,573.94 | 8,298,056.68 | ||||||||||||||||||||||
Kevin Egan | 112,528,433.48 | 1,894,703.20 | 80,658.94 | 8,298,056.68 | ||||||||||||||||||||||
| Adriana Karaboutis | 100,915,091.48 | 12,605,074.20 | 983,629.94 | 8,298,056.68 | ||||||||||||||||||||||
| Jeffrey B. Kindler | 111,383,895.68 | 3,045,339.00 | 74,560.94 | 8,298,056.68 | ||||||||||||||||||||||
Patrick Lockwood-Taylor | 113,841,837.68 | 597,023.00 | 64,934.94 | 8,298,056.68 | ||||||||||||||||||||||
| Albert A. Manzone | 99,489,588.68 | 14,939,807.00 | 74,399.94 | 8,298,056.68 | ||||||||||||||||||||||
| Donal O'Connor | 112,382,133.68 | 2,039,984.00 | 81,677.94 | 8,298,056.68 | ||||||||||||||||||||||
| Geoffrey M. Parker | 113,134,088.68 | 1,290,574.00 | 79,132.94 | 8,298,056.68 | ||||||||||||||||||||||
Jonas Samuelson | 112,461,851.48 | 1,954,276.20 | 87,667.94 | 8,298,056.68 | ||||||||||||||||||||||
2.Ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor for the year ending December 31, 2025, and authorize, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor:
For | Against | Abstain | Broker Non-Votes | |||||||||||||||||
| 120,540,568.10 | 1,795,304.20 | 465,980.00 | — | |||||||||||||||||
3.Advisory vote on executive compensation:
For | Against | Abstain | Broker Non-Votes | |||||||||||||||||
| 112,569,658.90 | 1,779,850.72 | 154,286.00 | 8,298,056.68 | |||||||||||||||||
4.Renew the Board's authority to issue shares under Irish law:
For | Against | Abstain | Broker Non-Votes | |||||||||||||||||
| 122,145,864.16 | 585,228.14 | 70,759.00 | 1.00 | |||||||||||||||||
5.Renew the Board's authority to opt-out of statutory pre-emption rights under Irish law:
For | Against | Abstain | Broker Non-Votes | |||||||||||||||||
| 119,988,639.10 | 2,652,558.20 | 160,653.00 | 2.00 | |||||||||||||||||
6.Approve an increase in the maximum number of directors who may be appointed to the Board:
For | Against | Abstain | Broker Non-Votes | |||||||||||||||||
| 120,921,008.63 | 1,759,352.67 | 121,488.00 | 3.00 | |||||||||||||||||
7.Approve amendments to the Company's Articles of Association:
For | Against | Abstain | Broker Non-Votes | |||||||||||||||||
| 113,359,863.42 | 942,188.20 | 201,744.00 | 8,298,056.68 | |||||||||||||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| (Registrant) | ||||||||||||||
| PERRIGO COMPANY PLC | ||||||||||||||
| By: | /s/ Charles Atkinson | |||||||||||||
| Dated: | May 5, 2025 | Charles Atkinson | ||||||||||||
| General Counsel & Company Secretary | ||||||||||||||